Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study
- PMID: 23562006
- PMCID: PMC3707958
- DOI: 10.1016/j.biopsych.2013.02.016
Cortisol levels and risk for psychosis: initial findings from the North American prodrome longitudinal study
Abstract
Background: Studies of biomarkers of hypothalamic-pituitary-adrenal activity indicate that psychotic disorders are associated with elevated cortisol. This study examined cortisol levels in healthy control subjects and individuals who met clinical high-risk (CHR) criteria for psychosis. It was hypothesized that cortisol levels would be 1) elevated in the CHR group relative to control subjects, 2) positively correlated with symptom severity, and 3) most elevated in CHR patients who transition to psychotic level severity.
Methods: Baseline assessments were conducted at eight centers in the North American Prodrome Longitudinal Study. The present CHR sample included 256 individuals meeting the Scale for Prodromal Symptoms criteria and 141 control subjects, all of whom underwent baseline assessment and measurement of salivary cortisol.
Results: Consistent with previous reports, there was an effect of age on cortisol, with increases through the adolescent/early adult years. Analysis of covariance showed a main effect of diagnostic group, with the CHR group showing higher cortisol. There were modest, positive correlations of cortisol with baseline symptom severity, and analysis of covariance revealed higher baseline cortisol in those who transitioned to psychotic level symptoms when compared with healthy control subjects and CHR subjects who remitted.
Conclusions: The present findings add to accumulating evidence of heightened cortisol secretion in CHR individuals. The findings also indicate nonspecific associations between cortisol levels and symptom severity, as well as symptom progression. The role of hypothalamic-pituitary-adrenal activity in prediction of conversion to psychosis and its relation with other biomarkers of risk should receive attention in future research.
Keywords: Cortisol; high-risk; longitudinal; prodrome; psychosis; stress.
Copyright © 2013 Society of Biological Psychiatry. All rights reserved.
Figures
Comment in
-
Early clinical phenotypes, clinical staging, and strategic biomarker research: building blocks for personalized psychiatry.Biol Psychiatry. 2013 Sep 15;74(6):394-5. doi: 10.1016/j.biopsych.2013.07.004. Biol Psychiatry. 2013. PMID: 23968984 No abstract available.
Similar articles
-
Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort.Psychoneuroendocrinology. 2020 May;115:104649. doi: 10.1016/j.psyneuen.2020.104649. Epub 2020 Mar 7. Psychoneuroendocrinology. 2020. PMID: 32197198 Free PMC article.
-
Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.JAMA Psychiatry. 2016 Dec 1;73(12):1239-1248. doi: 10.1001/jamapsychiatry.2016.2479. JAMA Psychiatry. 2016. PMID: 27806157 Free PMC article.
-
The relations of age and pubertal development with cortisol and daily stress in youth at clinical risk for psychosis.Schizophr Res. 2016 Apr;172(1-3):29-34. doi: 10.1016/j.schres.2016.02.002. Epub 2016 Feb 20. Schizophr Res. 2016. PMID: 26905038 Free PMC article.
-
North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.J Nerv Ment Dis. 2015 May;203(5):328-35. doi: 10.1097/NMD.0000000000000290. J Nerv Ment Dis. 2015. PMID: 25919383 Free PMC article.
-
Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait?Schizophr Res. 2018 Sep;199:31-38. doi: 10.1016/j.schres.2018.04.017. Epub 2018 Apr 25. Schizophr Res. 2018. PMID: 29703661 Review.
Cited by
-
Enhancing Psychosis Risk Prediction Through Computational Cognitive Neuroscience.Schizophr Bull. 2020 Dec 1;46(6):1346-1352. doi: 10.1093/schbul/sbaa091. Schizophr Bull. 2020. PMID: 32648913 Free PMC article.
-
Hypothalamus and Post-Traumatic Stress Disorder: A Review.Brain Sci. 2023 Jun 29;13(7):1010. doi: 10.3390/brainsci13071010. Brain Sci. 2023. PMID: 37508942 Free PMC article. Review.
-
The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis.Psychoneuroendocrinology. 2017 Sep;83:58-64. doi: 10.1016/j.psyneuen.2017.04.017. Epub 2017 May 30. Psychoneuroendocrinology. 2017. PMID: 28595088 Free PMC article.
-
Forecasting Remission From the Psychosis Risk Syndrome With Mismatch Negativity and P300: Potentials and Pitfalls.Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Feb;6(2):178-187. doi: 10.1016/j.bpsc.2020.10.010. Epub 2020 Oct 24. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021. PMID: 33431345 Free PMC article. Review.
-
Selective Review of Neuroimaging Findings in Youth at Clinical High Risk for Psychosis: On the Path to Biomarkers for Conversion.Front Psychiatry. 2020 Sep 23;11:567534. doi: 10.3389/fpsyt.2020.567534. eCollection 2020. Front Psychiatry. 2020. PMID: 33173516 Free PMC article. Review.
References
-
- Walker E, Mittal V, Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psycho. 2008;4:189–216. - PubMed
-
- Guest PC, Schwarz E, Krishnamurthy D, Harris LW, Leweke FM, Rothermundt M, et al. Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia. Psychoneuroendocrinology. 2011;36(7):1092–1096. - PubMed
-
- Steen NE, Tesli M, Kahler AK, Methlie P, Hope S, Barrett EA, et al. SRD5A2 is associated with increased cortisol metabolism in schizophrenia spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(8):1500–1506. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 5R2-R21-MH079189/MH/NIMH NIH HHS/United States
- R21 MH068513/MH/NIMH NIH HHS/United States
- U01 MH081902/MH/NIMH NIH HHS/United States
- R21 MH083138/MH/NIMH NIH HHS/United States
- U01MH0819188/MH/NIMH NIH HHS/United States
- 1-R21-MH068513/MH/NIMH NIH HHS/United States
- U01 MH076989/MH/NIMH NIH HHS/United States
- K24 MH076191/MH/NIMH NIH HHS/United States
- U01 MH08022/MH/NIMH NIH HHS/United States
- R21 MH079189/MH/NIMH NIH HHS/United States
- 1-R21-MH083138-1/MH/NIMH NIH HHS/United States
- K24 MH76191/MH/NIMH NIH HHS/United States
- U01 MH082022/MH/NIMH NIH HHS/United States
- U01 MH081984/MH/NIMH NIH HHS/United States
- U01 MH081988/MH/NIMH NIH HHS/United States
- U01 MH82022/MH/NIMH NIH HHS/United States
- R01 MH 60720/MH/NIMH NIH HHS/United States
- R01 MH092512/MH/NIMH NIH HHS/United States
- L30 MH095165/MH/NIMH NIH HHS/United States
- 1R01-MH092512/MH/NIMH NIH HHS/United States
- R01 MH060720/MH/NIMH NIH HHS/United States
- U01 MH081928/MH/NIMH NIH HHS/United States
- U01 MH082004/MH/NIMH NIH HHS/United States
- U01 MH081944/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous